1. Home
  2. CABA vs HITI Comparison

CABA vs HITI Comparison

Compare CABA & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • HITI
  • Stock Information
  • Founded
  • CABA 2017
  • HITI 2009
  • Country
  • CABA United States
  • HITI Canada
  • Employees
  • CABA N/A
  • HITI N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • HITI
  • Sector
  • CABA Health Care
  • HITI
  • Exchange
  • CABA Nasdaq
  • HITI Nasdaq
  • Market Cap
  • CABA 157.4M
  • HITI 187.8M
  • IPO Year
  • CABA 2019
  • HITI N/A
  • Fundamental
  • Price
  • CABA $1.59
  • HITI $2.29
  • Analyst Decision
  • CABA Strong Buy
  • HITI Strong Buy
  • Analyst Count
  • CABA 8
  • HITI 2
  • Target Price
  • CABA $18.88
  • HITI $4.75
  • AVG Volume (30 Days)
  • CABA 3.0M
  • HITI 280.7K
  • Earning Date
  • CABA 08-07-2025
  • HITI 06-16-2025
  • Dividend Yield
  • CABA N/A
  • HITI N/A
  • EPS Growth
  • CABA N/A
  • HITI N/A
  • EPS
  • CABA N/A
  • HITI N/A
  • Revenue
  • CABA N/A
  • HITI $398,202,371.00
  • Revenue This Year
  • CABA N/A
  • HITI $12.43
  • Revenue Next Year
  • CABA N/A
  • HITI $11.39
  • P/E Ratio
  • CABA N/A
  • HITI N/A
  • Revenue Growth
  • CABA N/A
  • HITI 9.22
  • 52 Week Low
  • CABA $0.99
  • HITI $1.57
  • 52 Week High
  • CABA $8.77
  • HITI $3.62
  • Technical
  • Relative Strength Index (RSI)
  • CABA 40.55
  • HITI 52.93
  • Support Level
  • CABA $1.65
  • HITI $2.24
  • Resistance Level
  • CABA $1.83
  • HITI $2.35
  • Average True Range (ATR)
  • CABA 0.17
  • HITI 0.09
  • MACD
  • CABA -0.06
  • HITI 0.01
  • Stochastic Oscillator
  • CABA 8.33
  • HITI 71.43

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

Share on Social Networks: